DOC
Healthpeak Properties
$19.98
▲ 2.1%Updated Today 7:15 PM ET
▲ Up 14.7% over the last 12 months
Market Cap
$13.82B
P/E
63.25x
Forward P/E (est.)
78.85x
ROE
2.9%
Revenue Growth
2.7%
EPS Growth
-19.8%
Profit Margin
7.7%
FCF Yield
5.0%
Debt / Equity
1.31x
ROIC
—
Interest Coverage
—
Current Ratio
—
Dividend Yield
6.0%
Implied Growth (rev. DCF)
6.3%
Rating Score
23/100
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what DOC's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. DOC trades near $19.98, above its 50-day average ($18.47) and 200-day average ($17.75). Price above both averages, with the shorter one above the longer, is the textbook definition of an uptrend — momentum favours buyers.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 49 it is in neutral territory — neither stretched nor washed out.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently negative — short-term momentum is fading.
Volatility — ATR. Average True Range is the typical daily move. DOC's is $0.53 (~2.7% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. Over the last month DOC found buyers near $18.90 (support) and sellers near $20.82 (resistance); its 52-week range is $15.70–$20.82. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 0.6× the 20-day average — lighter than usual, so the move carries less conviction. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.
Healthpeak Properties (DOC) is a large-cap company in the Health Care REITs industry, part of the Real Estate sector of the S&P 500, with a market value around $13.82B.
In its latest reported year it generated about $603.99M in revenue and $71.35M in net profit.
Our model rates DOC Weak (23/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
4Y CAGR
6.4%
Revenue moved from $471.32M in 2021 to $603.99M in 2025, a 6.4% compound annual growth rate. The most recent year was roughly flat (2.7%) year over year. Slower, mature growth is common for established businesses.
Gross Margin
58.9%
Operating Margin
21.7%
Net Margin
11.8%
ROE
2.9%
Healthpeak Properties keeps about 7.7% of each sales dollar as net profit, with a 58.9% gross margin and 21.7% operating margin. Return on equity is 2.9%. Margins are moderate — typical of a competitive but profitable business.
Total Debt
$10.42B
Net Debt
$9.25B
Net Debt / EBITDA
—
Debt / Equity
1.31x
Leverage: debt-to-equity is 1.3x. That is a moderate, manageable debt load for most businesses. It carries roughly $10.42B of total debt against $1.17B of cash.
Operating CF
$1.25B
Free Cash Flow
$357.01M
FCF Margin
59.1%
In the latest year Healthpeak Properties produced about $1.25B of operating cash flow and $357.01M of free cash flow after capital spending. That is a free-cash-flow yield of about 5.0% on today's price. Strong cash generation funds dividends, buybacks, and reinvestment.
P/E
63.25x
P/S
5.11x
P/B
1.49x
EV / EBITDA
—
DOC trades at 63.3x trailing earnings (about 78.8x on estimated forward earnings), 5.1x sales, and 1.5x book value. Reverse-engineering today's price implies the market expects roughly 6.3% long-term free-cash-flow growth. That is a rich multiple that prices in a lot of future growth.
Where this stock sits versus what most companies trade at.
Typical ranges are general references (e.g., many stocks trade at ~18–26x earnings), not hard rules. Context only — not investment advice.
How DOC stacks up against its Real Estate peers — valuation, profitability, and growth versus the sector median.
In the Real Estate sector (31 S&P 500 companies), DOC ranks #31 of 31 by our overall rating. It trades at a premium versus the sector on earnings (63.3x P/E vs. 30.8x median) with a lower return on equity (2.9% vs. 8.0%) and slower revenue growth (2.7% vs. 5.3%).
P/E vs sector
63.3x
median 30.8x
ROE vs sector
2.9%
median 8.0%
Growth vs sector
2.7%
median 5.3%
Sector rank
#31
of 31 by rating
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Real Estate companies by sub-industry and size. Sector median is across all 31 S&P 500 names in the sector. Educational, not a recommendation.
Project revenue → earnings → price. Edit the assumptions to build your own case.
2030 price target (Base Case)
$4.63 – $7.68
vs. $19.98 today · expected CAGR -25% – -17%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $622.11M | $640.77M | $660.00M | $679.79M | $700.19M |
| Net income | $74.65M | $76.89M | $79.20M | $81.58M | $84.02M |
| EPS | $0.11 | $0.11 | $0.11 | $0.12 | $0.12 |
| Share price (low) | $4.11 | $4.24 | $4.37 | $4.50 | $4.63 |
| Share price (high) | $6.82 | $7.03 | $7.24 | $7.45 | $7.68 |
| CAGR (low–high) | -79% / -66% | -54% / -41% | -40% / -29% | -31% / -22% | -25% / -17% |
Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.
The case for DOC:
- Healthy free-cash-flow yield (~5.0%) funds buybacks and dividends.
- Pays a 6.0% dividend on top of any price gains.
The case against DOC:
- Revenue growth is slow (2.7%), limiting the upside engine.
- A rich 63.3x earnings multiple prices in a lot of growth.
- Our model's overall read is Weak (23/100).
Valuation risk — at 63.3x earnings, disappointing results could compress the multiple.
Balance-sheet risk — debt/equity of 1.3x magnifies the impact of higher rates or weaker earnings.
Growth risk — sluggish revenue (2.7%) leaves little margin for execution missteps.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the fundamentals screen weakly: Healthpeak Properties is a large-cap real estate business growing at a mature pace, with modest profitability, and a heavier debt load to watch. It trades at 63.3x earnings, which our model scores Weak (23/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.